Sexually Transmitted Infections (STI) in Remote communities: ImproVed & Enhanced primary health care

Not Applicable

Completed

• Conditions: Sexually transmitted infections; Infection - Sexually transmitted infections

• Registration Number: ACTRN12610000358044
• Lead Sponsor: The University of New South Wales

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-05-06
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

Communities that meet the following criteria: - Considered remote by the Australian Bureau of Statistics (ABS) - With a resident population of at least 100 Aboriginal and/or Torres Strait Islander people aged 16 - 34 years - Community and health services willing and able to provide access to de-identified clinical data - Health services able to sustain data collection, consistent with trial protocol

Exclusion Criteria

Communities where there is a diverse range of health services that are accessed by Aboriginal and/or Torres Strait Islanders within the same location

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Best practice service delivery involving the diagnosis and treatment of the three STIs (chlamydia, gonorrhoea and trichomonas) in Aboriginal and/or Torres Strait Islander people, defined as: STI testing coverage, STI testing uptake, 3-month test for re-infection, time to treatment interval and named sexual contacts treated. This will be assessed by analysing results from health services' data reports. These data will indicate if health services have achieved the determined best practice service delivery levels.[Annually and at completion of the trial];Prevalence of chlamydia, gonorrhoea or trichomonas among 16-34 year olds. This will be measured using an annual prevalence survey: 50 male and 50 female Aboriginal and/or Torres Strait Islanders aged 16 - 34 residing in each cluster will be opportunisitically tested when they present at the health service.[Annually and at completion of the trial]